|
SLC39A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.555100E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.364700E-04 |
| Normal-vs-Stage2 |
1.828270E-04 |
| Normal-vs-Stage3 |
4.239600E-02 |
| Normal-vs-Stage4 |
3.223800E-01 |
| Stage1-vs-Stage2 |
1.461590E-01 |
| Stage1-vs-Stage3 |
7.186200E-02 |
| Stage1-vs-Stage4 |
1.379200E-01 |
| Stage2-vs-Stage3 |
2.335700E-02 |
| Stage2-vs-Stage4 |
3.735900E-02 |
| Stage3-vs-Stage4 |
6.720200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.818200E-04 |
| Normal-vs-AfricanAmerican |
7.448600E-01 |
| Normal-vs-Asian |
3.186100E-02 |
| Caucasian-vs-AfricanAmerican |
9.645800E-02 |
| Caucasian-vs-Asian |
6.462800E-01 |
| AfricanAmerican-vs-Asian |
2.077400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.686390E-02 |
| Normal-vs-Female |
5.355500E-04 |
| Male-vs-Female |
3.433600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.171600E-04 |
| Normal-vs-Age(41-60Yrs) |
9.192300E-04 |
| Normal-vs-Age(61-80Yrs) |
4.542400E-02 |
| Normal-vs-Age(81-100Yrs) |
3.682400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.138200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.919620E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.854800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.708000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.850800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.517200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.085620E-01 |
| Classical-VS-Follicular |
3.79979999687308E-08 |
| Classical-VS-Other |
1.327370E-01 |
| Classical-VS-Normal |
6.401800E-02 |
| Tall-VS-Follicular |
9.695900E-02 |
| Tall-VS-Other |
5.189000E-01 |
| Tall-VS-Normal |
4.577200E-03 |
| Follicular-VS-Other |
7.513200E-01 |
| Follicular-VS-Normal |
3.69729999949442E-08 |
| Other-VS-Normal |
1.536240E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.71144999999706E-05 |
| Normal-vs-N1 |
2.400900E-04 |
| N0-vs-N1 |
5.765400E-01 |
|
|
